Alumni.
Alumni hold a special place in the heart of our lab, Their diverse journeys post-lab demonstrate the versatility of skills and knowledge they acquired during their time with us. We are proud of our lab alumni who, as future researchers, continue to explore and discover.
Daniel J. (DJ) Doty, BS
Sr. Laboratory Specialist 2020- 2023
Current Position:
Sr. Laboratory Specialist, University of Utah
Feroz Ahmed Shaik
Postdoctoral Fellow 2020-2023
Research Emphasis:
Identifying Small Molecules Inhibiting Toll-like Receptor (TLR) Mediated Signaling and Inflammation.
Current Position:
Scientist at Popvax
Shaheer Ahmad, PhD
Postdoctoral Fellow 2020-2021
Research Emphasis:
Role of TNIP1 in SLE
Current Position:
Postdoctoral Fellow at La Jolla Institute for Immunology
Peter Daniels
Undergraduate Student 2017- 2018
Research Emphasis:
TNIP1 signaling and apoptosis
Current Position: Medical Student at VCU School of Medicine
Jeeba (Kuriakose) Bellot, PhD
Postdoctoral Fellow 2011-2017
Research Emphasis:
Role of patrolling monocytes in SLE
Publication:
Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis
A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity
SHARPIN controls the development of regulatory T cells
Current Position:
Associate Director Flow Cytometry and QC Assay Development at Immatics
_edited.jpg)
Sirish Ippagunta, PhD
Postdoctoral Fellow 2010-2015
Research Emphasis:
TLR drug development, cellular pathogenesis of psoriasis
Publication:
Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins
Triaryl Pyrazole Toll-Like Receptor Signaling Inhibitors: Structure-Activity Relationships Governing Pan- and Selective Signaling Inhibitors
Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function
Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis
Current Position:
Associate Professor at AIIMS (All India Institute of Medical Sciences, New Delhi)
Kazuki Tawaratsumida, PhD
Postdoctoral Fellow 2010-2016
Research Emphasis:
Molecular mechanisms of signal transduction, Influenza host- pathogen interaction
Publication:
Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor.
Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins
A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity
Current Position:
Research Associate Haecker Lab
Vandana Chaturvedi, PhD
Postdoctoral Fellow 2010-2013
Research Emphasis:
Role of Sharpin in T-cell differentiation
Publication:
SHARPIN controls the development of regulatory T cells.
Hematopoietic progenitor cell lines with myeloid and lymphoid potential
Current Position:
Scientist at Sana Biotechnology, Seattle
Juan P. Giraldo-Vela, PhD
Postdoctoral Fellow 2010-2012
(Redecke Lab)
Research Emphasis:
Identification of novel components of the T-cell receptor signaling pathway
Publication:
The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.
Current Position:
Infection Prevention Surveillance Analyst at Advocate Aurora Health
David Achila, PhD
Postdoctoral Fellow 2013-2015
Research Emphasis:
TNIP1 signaling and apoptosis
Current Position:
Manager, Quality Control Operations, CAR-T Manufacturing Cell Therapy at Bristol-Myers Squibb
Rohan Keshwara, PhD, CMPP
Undergraduate Student 2009
(Redecke Lab)
Research Emphasis:
Identify novel components of the T-cell receptor (TCR) signaling pathway
Current Position:
Senior Manager, Worldwide Publications (Hematology/Cell Therapy) at Bristol Myers Squibb
_edited_edited.jpg)
Cinthia Stempin, PhD
Postdoctoral Fellow 2008-2010
(Redecke Lab)
Research Emphasis:
Identification of novel components of the T-cell receptor signaling pathway
Publication:
The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.
Current Position:
Senior Researcher
CONICET Centre for Research in Clinical Biochemistry and Immunology (CIBICI)
Cordoba, Argentina
Liying Chi, MD
Sr Research Technologist 2008-2013 (Redecke Lab)
Publication:
The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.
Current Position:
Sr Research Technologist St Jude Children’s Research Hospital, Memphis
Ruiqiong Wu, PhD
Associate Scientist 2008-2019
Research Emphasis:
Identification of novel components of the T-cell receptor signaling pathway
Publication:
Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis.
Hematopoietic progenitor cell lines with myeloid and lymphoid potential.
Current Position:
Associate Scientist St Jude Children’s Research Hospital
_edited_edited.jpg)
Van Phan
Undergraduate Student 2009- 2013
Research Emphasis:
Molecular mechanisms of nfluenza host- pathogen interaction
Publication:
Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor.
Current Position:
Medical Student
Kim LeMessurier, PhD
Postdoctoral Fellow 2007-2011
(Redecke Lab)
Research Emphasis:
Host-pathogen interaction in Pneumoccal Disease
Publication:
Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung.
Inhibition of T cells provides protection against early invasive pneumococcal disease.
Current Position:
Lead Scientist at Children's GMP LLC/St. Jude Children's Research Hospital
Jennifer Hobbs, PhD
Postdoctoral Fellow 2007-2010
Research Emphasis:
Signaling via TRAF family members
Current Position:
Senior Vice President for Administration, Chief of Staff at The New School, New York
Jingran Zhou, MD, PhD
Postdoctoral Fellow 2006-2012
Research Emphasis:
Deciphering the function of TNIP1 (ABIN1)
Publication:
A20-binding inhibitor of NF-kappaB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein beta activation and protects from inflammatory disease
Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis
Sadly, Jingran passed away. She touched all of our lives profoundly and we miss her dearly.
Rafijul Bari, PhD
Postdoctoral Fellow 2006-2007
(Redecke Lab)
Research Emphasis:
CD28 receptor signaling
Current Position:
Director, Research and Early DevelopmentDirector, Research and Early Development
Celularity Inc.